Stem-cell-like CD4+ T cells prey on MHC class II–negative tumors

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 17, 2023
Source ID
10.1038/s41590-023-01563-5

Entities

People

  • Joshua R. Veatch
  • Stanley R Riddell

Organizations

  • National Institutes of Health
  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech